Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 9.52% |
| 3 | Healthcare | 7.46% |
| 4 | Financials | 6.74% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Axsome Therapeutics
AXSM
$10.4B
| $6.2M | ﹤0.01% |
33,937
+28,196
| +491% | +$3.94M |
|
2677
PUT
Cameco
CCJ
$43.6B
| $6.19M | ﹤0.01% |
67,700
+29,500
| +77% | +$2.66M |
|
2678
Freedom Holding
FRHC
$11.2B
| $6.19M | ﹤0.01% |
50,893
-70,611
| -58% | -$10.2M |
|
|
MICC
2679
The Magnum Ice Cream Company N.V.
MICC
$12.3B
| $6.19M | ﹤0.01% |
+390,636
| New | +$6.13M |
|
2680
CALL
Iron Mountain
IRM
$35B
| $6.19M | ﹤0.01% |
74,600
+39,300
| +111% | +$3.68M |
|
2681
New Oriental
EDU
$9.36B
| $6.17M | ﹤0.01% |
112,135
+43,166
| +63% | +$2.37M |
|
|
OS
2682
DELISTED
OneStream Inc
OS
| $6.17M | ﹤0.01% |
335,581
-368,195
| -52% | -$7.02M |
|
|
MOFG
2683
DELISTED
MidWestOne Financial Group
MOFG
| $6.17M | ﹤0.01% |
160,153
-37,369
| -19% | -$1.36M |
|
2684
Arthur J. Gallagher & Co
AJG
$68.6B
| $6.16M | ﹤0.01% |
23,788
-172,038
| -88% | -$45.5M |
|
2685
CALL
Parker-Hannifin
PH
$125B
| $6.15M | ﹤0.01% |
7,000
-14,200
| -67% | -$11.6M |
|
|
BLDP
2686
Ballard Power Systems
BLDP
$678M
| $6.14M | ﹤0.01% |
2,414,800
+350,395
| +17% | +$1.09M |
|
2687
Benchmark Electronics
BHE
$2.56B
| $6.14M | ﹤0.01% |
143,569
-197,888
| -58% | -$8.57M |
|
|
AII
2688
American Integrity Insurance
AII
$516M
| $6.14M | ﹤0.01% |
294,576
+265,867
| +926% | +$5.91M |
|
|
RAPP
2689
Rapport Therapeutics
RAPP
$2.34B
| $6.12M | ﹤0.01% |
201,825
+47,651
| +31% | +$1.32M |
|
2690
ENI
E
$76.1B
| $6.12M | ﹤0.01% |
161,359
-28,924
| -15% | -$1.06M |
|
|
TSSI
2691
TSS Inc
TSSI
$230M
| $6.12M | ﹤0.01% |
865,350
+489,497
| +130% | +$6.33M |
|
2692
Recursion Pharmaceuticals
RXRX
$1.79B
| $6.12M | ﹤0.01% |
+1,495,839
| New | +$7.41M |
|
2693
DiaMedica Therapeutics
DMAC
$345M
| $6.12M | ﹤0.01% |
768,560
-418,749
| -35% | -$3.13M |
|
2694
Atmus Filtration Technologies
ATMU
$3.89B
| $6.11M | ﹤0.01% |
117,797
-22,072
| -16% | -$1.07M |
|
2695
Old Second Bancorp
OSBC
$1.28B
| $6.11M | ﹤0.01% |
+313,560
| New | +$5.86M |
|
2696
Denali Therapeutics
DNLI
$3.84B
| $6.1M | ﹤0.01% |
369,767
-937,404
| -72% | -$15.8M |
|
2697
TriMas Corp
TRS
$1.42B
| $6.09M | ﹤0.01% |
171,719
+59,373
| +53% | +$2.07M |
|
2698
PUT
Abercrombie & Fitch
ANF
$6.59B
| $6.08M | ﹤0.01% |
48,300
-86,700
| -64% | -$7.58M |
|
2699
Acadia Healthcare
ACHC
$2.66B
| $6.08M | ﹤0.01% |
428,304
+180,787
| +73% | +$3.42M |
|
2700
Xometry
XMTR
$5.39B
| $6.08M | ﹤0.01% |
102,191
+68,721
| +205% | +$3.87M |
|
Similar funds
Israel Englander's Q4 2025 Portfolio in Review
As of Q4 2025, Israel Englander held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Israel Englander's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Israel Englander's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Israel Englander fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Israel Englander's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Israel Englander opened 668 new positions and closed 696 in Q4 2025.
- Israel Englander's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.